Silbert

Cassava | Tomorrow - scheduled end of phase IIb | Jackpot?

Long
Silbert Updated   
NASDAQ:SAVA   Cassava Sciences, Inc.
Is SAVA about to blow up soon? The phase IIb will be most likely done by tomorrow whereby the analysis and evaluation of the results is scheduled for May. So there might be one last pullback before the stock will pulverize the last highs (in case the results are positive!). As a consequence of that I will look for good entries to ride the stock to at least 20$ per share :).
Comment:
Launch successful :). The NIH is funding another $2.5 million, which might be a good sign for positive phase 2b results.
Comment:
The results aren't published yet, but the expectations grow! The stock is rising sharply :)

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.